Form 8-K - Current report

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 24, 2024

VSEE HEALTH, INC.

(Exact name of registrant as specified in its charter)

Delaware		001-41015		86-2970927
(State or other jurisdiction of incorporation)		(Commission File Number)		(I.R.S. Employer Identification No.)

980 N Federal Hwy #304 Boca Raton, Florida		33432
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (754) 231-1688

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Title of each class	Trading Symbol	Name of each exchange on which registered
Common Stock, $0.0001 par value per share	VSEE	The Nasdaq Stock Market LLC
Warrants, which entitles the holder to purchase one (1) share of common stock at a price of $11.50 per whole share	VSEEW	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company x

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 7.01. Regulation FD Disclosure.

On July 24, 2024, VSee Health, Inc. (the “Company”) issued a press release announcing that the Company has partnered with SkywardRx, a digital healthcare services and consulting firm, to provide telehealth and billing services to SkywardRx’s nonprofit, hospital and Fortune 20 corporate clients. A copy of the press release is furnished as Exhibit 99.1 hereto and incorporated herein by reference.

The information included in this Item 7.01 and Exhibit 99.1 of this Current Report on Form 8-K is not deemed to be “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall this item and Exhibit 99.1 be incorporated by reference into the Company’s filings under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such future filing.

Item 9.01. Financial Statement and Exhibits.

Exhibit Number		Description
99.1		Press Release dated July 24, 2024
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: July 29, 2024	VSEE HEALTH, INC.

	By:	/s/ Imoigele Aisiku
	Name:	Imoigele Aisiku
	Title:	Co-Chief Executive Officer

Exhibit 99.1

VSee Health to Provide Telehealth and Billing Services to SkywardRx Clients

SAN JOSE, Calif., July 24, 2024 -- VSee Health, Inc. (NASDAQ: VSEE), a provider of comprehensive telehealth services that customize telehealth workflow streams, enhance patient care and turnkey billing services, announces it has partnered with SkywardRx, a digital healthcare services and consulting firm, to provide telehealth and billing services to SkywardRx’s nonprofit, hospital and Fortune 20 corporate clients. This partnership allows both organizations to expand their shared commitment of optimizing patient access within critical areas of healthcare delivery including behavioral health, nutritional wellness and substance abuse, while reducing overall healthcare cost for both the patient and provider.

"This new partnership is an important step in our mission to improve healthcare delivery and access for the most vulnerable patient populations," said Imo Aisiku, M.D., co-CEO and Chairman of VSee Health. "By combining VSee’s turnkey technology and billing services with SkywardRx’s personal consulting services, we have the opportunity to advance our commitment of optimizing the patient experience and reducing healthcare costs for both patients and healthcare providers. This partnership has the potential to expand our services to the approximately five million patients served by SkywardRx and their clients."

"We are incredibly excited to partner with VSee Health, bringing together the best in healthcare technology and patient engagement," said Dave Rike, co-Founder and CRO of SkywardRx. "VSee Health’s billing and telehealth services are a critical component in delivering better health outcomes to our clients. Our customer base includes national nonprofits, health systems, employer groups and individuals looking to save money and improve their health."

About VSee Health

VSee Health is a software-as-a-service (SaaS) platform that enables clinicians and enterprises to create their telehealth workflows without programming. VSee Health’s system allows a telehealth mobile app to be created or a telehealth system to be integrated into existing hospital operations in days.

With a focus on patient disease state telemedicine and turnkey billing services, VSee Health has integrated an intensive care, critical care and neuro solution, powered by iDoc Telehealth Solutions, as its initial module for the VSee Health software platform. This technology encompasses a set of integrated telehealth technologies and a team of neurointensivists, neurologists, tele-radiologists that treat and coordinate care for acutely ill patients 24/7/365 in the neurointensive care unit (Neuro-ICU), cardiac surgery intensive care unit (CS-ICU) and the intensive care unit (ICU) for stroke, brain trauma and a wide range of neurological conditions. For more information, please visit www.vseehealth.com.

About SkywardRx

SkywardRx stands as a leading healthcare consulting firm with a distinguished track record of collaboration with non-profits, hospitals, and Fortune 20 companies. Co-founders Dave Rike and Alex Whitacre, both industry stalwarts with over 30 years of combined healthcare experience, bring a wealth of knowledge and success, having successfully built various healthcare enterprises throughout their careers. Their commitment to driving positive change in the healthcare landscape stands as the cornerstone of SkywardRx's mission. Learn more at www.skywardrx.com.

Forward-Looking Statements

Matters discussed in this release that are not statements of historical or current facts, including but not limited to those relating to VSee Health’s ability to improve healthcare access and Provider efficiencies, are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause performance or achievements to be materially different from historical results or from any future performance or achievements expressed or implied by such forward-looking statements. Accordingly, readers should not place undue reliance on any forward-looking statements. More information on risk factors relating to VSee and its technology and billing services is included from time to time in the "Cautionary Note Regarding Forward-Looking Statements," "Risk Factors" and "Management’s Discussion and Analysis of Financial Condition and Results of Operations" sections of VSee’s periodic and current filings with the SEC, which are also made available on VSee’s website at www.vseehealth.com. Forward-looking statements speak only as of the date they are made, and VSee undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise that occur after that date, or otherwise.

Contacts

LHA Investor Relations

Tirth T. Patel

212-201-6614

tpatel@lhai.com

Cover	Jul. 24, 2024
Document Type	8-K
Amendment Flag	false
Document Period End Date	Jul. 24, 2024
Entity File Number	001-41015
Entity Registrant Name	VSEE HEALTH, INC.
Entity Central Index Key	0001864531
Entity Tax Identification Number	86-2970927
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	980 N Federal Hwy #304
Entity Address, City or Town	Boca Raton
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	33432
City Area Code	754
Local Phone Number	231-1688
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false
Common Stock [Member]
Title of 12(b) Security	Common Stock, $0.0001 par value per share
Trading Symbol	VSEE
Security Exchange Name	NASDAQ
Warrant [Member]
Title of 12(b) Security	Warrants, which entitles the holder to purchase one (1) share of common stock at a price of $11.50 per whole share
Trading Symbol	VSEEW
Security Exchange Name	NASDAQ